Research map: Authors’ response: low-voltage area ablation in atrial fibrillation

Back to the article

Papers in this map

  1. Low-Voltage Myocardium-Guided Ablation Trial of Persistent Atrial Fibrillation · Yan Huo · 2022 · 277 citations · Cited by this paper
  2. Cilostazol for heart rate increase in atrial fibrillation with slow ventricular response: an exploratory randomized controlled trial · 2026 · Related
  3. Atrial Structural Remodeling in Patients With Atrial Fibrillation Is a Diffuse Fibrotic Process: Evidence From High‐Density Voltage Mapping and Atrial Biopsy · Takanori Yamaguchi · 2022 · 102 citations · Cited by this paper
  4. Finerenone vs. spironolactone to reduce adverse outcomes in patients with cardiac–kidney–metabolic syndrome complicated by atrial fibrillation: findings from the Tianjin atrial fibrillation project · 2026 · Related
  5. Low-voltage-area ablation for persistent atrial fibrillation: a randomized controlled trial · Masaharu Masuda · 2025 · 50 citations · Cited by this paper
  6. Risk factors for cardiac death in women with coronary artery disease · 2026 · Related
  7. Pulsed Field Ablation of Atrial Fibrillation: A Comprehensive Review · Carlos D. Matos · 2023 · 25 citations · Cited by this paper
  8. Cardiac autonomic function in elderly patients with and without atrial fibrillation · 2026 · Related
  9. Left Atrial Localized Low-Voltage Areas Indicate Whole Left Atrial Electrophysiological Degeneration in Atrial Fibrillation Patients · Naoya Kurata · 2021 · 18 citations · Cited by this paper
  10. Left bundle branch area pacing: anatomical and physiological features made easy · 2026 · Related
  11. Efficacy of Low-Voltage-Area Ablation Is Enhanced in Patients With Advanced Left Atrial Enlargement: A Subanalysis of the SUPPRESS-AF Trial · Masaharu Masuda · 2025 · 7 citations · Cited by this paper
  12. From simulator to patient: transfer of procedural skills to practice in cardiac device implantation · 2026 · Related
  13. Efficacy of Low‐Voltage Area Ablation Across Substrate Size in Persistent Atrial Fibrillation: A Post Hoc Analysis of the SUPPRESS‐AF Randomized Trial · Masato Okada · 2025 · 3 citations · Cited by this paper
  14. Asymptomatic and symptomatic cardiac toxicity associated with immune checkpoint inhibitors: insights from a Japanese registry · 2026 · Related
  15. Angiotensin-converting enzyme inhibitors show an edge over angiotensin II receptor blockers in cardiovascular outcomes · 2026 · Related
  16. Impact of chronic kidney disease on clinical outcomes among patients with atrial fibrillation following percutaneous left atrial appendage occlusion: a multicentre cohort study · 2026 · Related

Source: OpenAlex (CC0)